What's Hot

    The Future of Regulatory Technology: How RTOP and the Big 4 Are Shaping Compliance Trends

    September 12, 2023

    Elon Musk Flaunts Vast Competitive Edge — Auto Industry ‘Still Hasn’t Caught Up’ With Tesla From 10 Years Ago – Tesla (NASDAQ:TSLA)

    August 10, 2023

    Taylor Swift’s ‘Eras Tour’ Toronto Tickets Listed At $16K, Leaving Fans Aghast

    August 10, 2023
    Facebook Twitter Instagram YouTube LinkedIn TikTok Telegram
    Telegram
    InformatemiInformatemi
    Subscribe
    • Home
    • Blog
    • Contact
    InformatemiInformatemi
    Home»News»Needham Reiterates Paragon 28, Inc. (FNA) Buy Recommendation
    News

    Needham Reiterates Paragon 28, Inc. (FNA) Buy Recommendation

    FintelBy FintelApril 21, 2023Updated:April 21, 20233 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    [ad_1]

    Fintel reports that on April 20, 2023, Needham reiterated coverage of Paragon 28, Inc. (NYSE:FNA) with a Buy recommendation.

    Analyst Price Forecast Suggests 56.58% Upside

    As of April 6, 2023, the average one-year price target for Paragon 28, Inc. is $28.56. The forecasts range from a low of $24.24 to a high of $33.60. The average price target represents an increase of 56.58% from its latest reported closing price of $18.24.

    See our leaderboard of companies with the largest price target upside.

    The projected annual revenue for Paragon 28, Inc. is $219MM, an increase of 20.72%. The projected annual non-GAAP EPS is -$0.31.

    What are Other Shareholders Doing?

    IMPAX – ERShares US Small Cap Fund Institutional Class holds 17K shares representing 0.02% ownership of the company. In it’s prior filing, the firm reported owning 17K shares, representing an increase of 0.58%. The firm increased its portfolio allocation in FNA by 6.71% over the last quarter.

    WMICX – Wasatch Micro Cap Fund Investor Class shares holds 292K shares representing 0.36% ownership of the company. In it’s prior filing, the firm reported owning 428K shares, representing a decrease of 46.40%. The firm decreased its portfolio allocation in FNA by 18.88% over the last quarter.

    WAMCX – Wasatch Ultra Growth Fund Investor Class shares holds 894K shares representing 1.09% ownership of the company. In it’s prior filing, the firm reported owning 1,204K shares, representing a decrease of 34.67%. The firm decreased its portfolio allocation in FNA by 16.75% over the last quarter.

    Ameritas Investment Partners holds 3K shares representing 0.00% ownership of the company. No change in the last quarter.

    Invesco holds 26K shares representing 0.03% ownership of the company. In it’s prior filing, the firm reported owning 14K shares, representing an increase of 47.32%. The firm decreased its portfolio allocation in FNA by 99.98% over the last quarter.

    What is the Fund Sentiment?

    There are 211 funds or institutions reporting positions in Paragon 28, Inc.. This is an increase of 21 owner(s) or 11.05% in the last quarter. Average portfolio weight of all funds dedicated to FNA is 0.57%, an increase of 420.37%. Total shares owned by institutions increased in the last three months by 70.85% to 33,827K shares. FNA / Paragon 28, Inc. Common Stock Put/Call Ratios The put/call ratio of FNA is 0.58, indicating a bullish outlook.

    Paragon 28 Background Information
    (This description is provided by the company.)

    Paragon 28®, Inc. was established in 2010 to address the unmet and under-served needs of the foot and ankle community. From the onset, Paragon 28® has made it its goal to re-invent the space of foot and ankle surgery. The companies believes that through research and innovation Paragon can create new and improved solutions to the challenges faced by foot and ankle specialists.

    See all Paragon 28, Inc. regulatory filings.

    This story originally appeared on Fintel.

    The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

    [ad_2]

    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleProcter & Gamble, CSX And 3 Stocks To Watch Heading Into Friday – HCA Healthcare (NYSE:HCA), CSX (NASDAQ:CSX)
    Next Article EF Hutton Reiterates Direct Digital Holdings Inc (DRCT) Buy Recommendation
    Fintel

    Related Posts

    The Future of Regulatory Technology: How RTOP and the Big 4 Are Shaping Compliance Trends

    September 12, 2023

    Taylor Swift’s ‘Eras Tour’ Toronto Tickets Listed At $16K, Leaving Fans Aghast

    August 10, 2023

    Cs Disco (LAW) Q2 2023 Earnings Call Transcript

    August 10, 2023
    Top Posts

    The Future of Regulatory Technology: How RTOP and the Big 4 Are Shaping Compliance Trends

    September 12, 2023

    Taylor Swift’s ‘Eras Tour’ Toronto Tickets Listed At $16K, Leaving Fans Aghast

    August 10, 2023

    Cs Disco (LAW) Q2 2023 Earnings Call Transcript

    August 10, 2023

    Subscribe to Updates

    Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

    [wpforms id="4157" title="false"]

    Gain access to our Newsletter, SMS Alerts, and Telegram Community for FREE

    Top Insights

    The Future of Regulatory Technology: How RTOP and the Big 4 Are Shaping Compliance Trends

    September 12, 2023

    Elon Musk Flaunts Vast Competitive Edge — Auto Industry ‘Still Hasn’t Caught Up’ With Tesla From 10 Years Ago – Tesla (NASDAQ:TSLA)

    August 10, 2023

    Taylor Swift’s ‘Eras Tour’ Toronto Tickets Listed At $16K, Leaving Fans Aghast

    August 10, 2023
    Get Informed

    Subscribe to Updates

    Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

    [wpforms id="4157" title="false"]
    Facebook Twitter Instagram YouTube LinkedIn TikTok
    • Privacy Policy
    • Disclaimer
    • SMS Squeeze
    • Sign Up
    © 2023 Informatemi

    Type above and press Enter to search. Press Esc to cancel.